BIO earnings date and history (2026)
Bio-Rad Laboratories Inc. (BIO) has no scheduled report date on the calendar yet. Its last report, on Wed Nov 4, came in at $2.65 against a $2.61 consensus; the stock moved -2.9% on the news. Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Data provided bySource: Twelve DataNewest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s timing is established — the earnings calendar, the time the company filed its earnings release with the SEC and the day’s trading volume, by majority.
| Date | Est | Actual | Move |
|---|---|---|---|
| Nov 4, 2026 | $2.61 | $2.65 | -2.9% |
| Aug 4, 2026 | $2.34 | $2.62 | +4.5% |
| Apr 30, 2026 | $2.77 | $1.89 | -8.4% |
| Feb 12, 2026 | $2.57 | $2.51 | -12.3% |
| Oct 29, 2025 | $2.30 | $2.26 | -4.7% |
| Jul 31, 2025 | $1.93 | $2.61 | +17.6% |
| May 1, 2025 | $1.73 | $2.54 | -1.7% |
| Feb 13, 2025 | $2.93 | $2.90 | -9.5% |
| Oct 30, 2024 | $1.28 | $2.01 | +8.4% |
| Aug 1, 2024 | $2.12 | $3.11 | -1.6% |
| May 7, 2024 | $2.04 | $2.29 | -4.2% |
| Feb 15, 2024 | $2.93 | $3.10 | +3.6% |
| Oct 26, 2023 | $2.87 | $2.33 | -7.2% |
| Aug 3, 2023 | $2.55 | $3.00 | -0.4% |
| May 4, 2023 | $3.24 | $3.34 | -16.7% |
| Feb 16, 2023 | $3.45 | $3.31 | +6.0% |
| Oct 27, 2022 | $2.59 | $2.60 | -8.0% |
| Jul 28, 2022 | $2.46 | $3.38 | +0.6% |
| Apr 28, 2022 | $2.80 | $4.94 | -0.2% |
| Feb 10, 2022 | $2.87 | $3.21 | +0.7% |
| Oct 28, 2021 | $2.30 | $3.71 | +0.7% |
| Jul 29, 2021 | $1.90 | $3.54 | +4.6% |
About this data#
Report dates, sessions, consensus EPS estimates, reported EPS and surprises are third-party figures, subject to change, and may not be accurate. A quarter whose session is known is shown with it; for one whose session is not, the move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- Did BIO beat earnings last quarter?
- Yes: on Wed Nov 4 BIO reported $2.65 against a $2.61 consensus, a +1.5% surprise.
- How did BIO stock react to its last earnings?
- BIO moved -2.9% on its last earnings report. It reported on Wed Nov 4, 2026, after the close, so the first trading session that could react was Thu Nov 5. BIO closed at $379.99 on Wed Nov 4 and at $369.00 on Thu Nov 5, and $369.00 ÷ $379.99 − 1 = -2.9%. Both are ChartRow's own settled closing prices.